Your account is not claimed yet. You can sign up with ORCID to claim your account.

Martin Faehling (M Faehling)

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 3

Top Topics

Ejection Fraction

Small Cell Lung Cancer

Brain Metastases

Epidermal Growth Factor Receptor

Top Venues

Journal of cancer research and clinical oncology

Therapeutic advances in medical oncology

Klinikum Esslingen

University of Oxford (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Klinikum Esslingen

Germany

Ltd. Arzt Pneumologie :: Klinik für Kardiologie und Pneumologie

Education History

University of Oxford

United Kingdom

MSC :: Physiology

Publications

Martin Faehling, Hanno Witte, Martin Sebastian, Matthias Ulmer, Rainer Sätzler, Konrad Steinestel, Wolfgang M Brückl, Georg Evers, Christian Meyer Zum Büschenfelde, Annalen Bleckmann
Real-world multicentre analysis of neoadjuvant immunotherapy and chemotherapy in localized or oligometastatic non-small cell lung cancer (KOMPASSneoOP). Therapeutic advances in medical oncology 14 (2022)
Martin Faehling, J Achenbach, P Staib, U Steffen, H W Tessen, V E Gaillard, W Brugger
Erlotinib in routine clinical practice for first-line maintenance therapy in patients with advanced non-small cell lung cancer (NSCLC). Journal of cancer research and clinical oncology 144 (7) (2018)
Martin Faehling, Birgit Schwenk, Sebastian Kramberg, Sabine Fallscheer, Matthias Leschke, Jörn Sträter, Robert Eckert
Second malignancy in non-small cell lung cancer (NSCLC): prevalence and overall survival (OS) in routine clinical practice. Journal of cancer research and clinical oncology 144 (10) (2018)